Works matching IS 02533766 AND DT 2021 AND VI 43 AND IP 9


Results: 16
    1

    免疫检查点抑制剂相关超进展一例.

    Published in:
    Chinese Journal of Oncology, 2021, v. 43, n. 9, p. 979, doi. 10.3760/cma.j.cn112152-20200502-00403
    By:
    • 张静怡;
    • 彭艳梅;
    • 谭可欣;
    • 申文;
    • 张旭;
    • 孙晨耀;
    • 崔慧娟
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8

    正常免疫小鼠人源结肠癌移植瘤模型的建立.

    Published in:
    Chinese Journal of Oncology, 2021, v. 43, n. 9, p. 939, doi. 10.3760/cma.j.cn112152-20190915-00596
    By:
    • 程姝敏;
    • 刘建玲;
    • 谌通;
    • 毕研贞;
    • 刘昆燕;
    • 王全义;
    • 唐慧昕;
    • 杨永红;
    • 张小蓓;
    • 胡瑞瑞;
    • 刘素芹;
    • 张凯;
    • 孔令斌;
    • 郭道路;
    • 舒振锋;
    • 洪丰
    Publication type:
    Article
    9
    10
    11
    12

    宫颈癌的流行病学趋势.

    Published in:
    Chinese Journal of Oncology, 2021, v. 43, n. 9, p. 912, doi. 10.3760/cma.j.cn112152-20190904-00573
    By:
    • 李道娟;
    • 师金;
    • 靳晶;
    • 杜耐一;
    • 贺宇彤
    Publication type:
    Article
    13
    14
    15
    16

    抗肿瘤药物分级管理专家共识.

    Published in:
    Chinese Journal of Oncology, 2021, v. 43, n. 9, p. 897, doi. 10.3760/cma.j.cn112152-20210720-00528
    By:
    • 戴媛媛;
    • 李国辉;
    • 赫捷
    Publication type:
    Article